SAN RAFAEL, Calif.,
June 3, 2020 /PRNewswire/ -- BioMarin
Pharmaceutical Inc. (NASDAQ: BMRN) today announced that
Jean-Jacques Bienaimé, Chairman and Chief Executive Officer;
Henry Fuchs, M.D., President,
Worldwide Research & Development; and Brian Mueller, Acting Chief Financial Officer,
will participate in the Jefferies Virtual Healthcare Conference on
June 4, 2020 at 4:00pm ET and the Goldman Sachs 41st Annual
Global Healthcare Conference on June 9,
2020 at 2:10pm ET. An
audio webcast of the presentation will be available live. You can
access the webcast at: https://investors.biomarin.com/. An archived
version of the remarks will also be available through the Company's
website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company that develops and
commercializes innovative therapies for people with serious and
life-threatening rare disorders. The company's portfolio consists
of six commercialized products and multiple clinical and
pre-clinical product candidates.
For additional information, please visit www.biomarin.com.
Information on BioMarin's website is not incorporated by reference
into this press release.
|
Contacts:
|
|
|
Investors
|
Media
|
|
Traci
McCarty
|
Debra
Charlesworth
|
|
BioMarin
Pharmaceutical Inc.
|
BioMarin
Pharmaceutical Inc.
|
|
(415)
455-7558
|
(415)
455-7451
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-two-upcoming-virtual-investor-conferences-301069809.html
SOURCE BioMarin Pharmaceutical Inc.